Ustekinumab for successful treatment of refractory esophageal crohn's disease

Jodie A. Barkin; Amar R. Deshpande

doi:10.14309/crj.2016.15

Ustekinumab for successful treatment of refractory esophageal crohn's disease

Research output: Contribution to journal › Article › peer-review

Abstract

Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.

Original language	English (US)
Pages (from-to)	107-108
Number of pages	2
Journal	ACG Case Reports Journal
Volume	3
Issue number	2
DOIs	https://doi.org/10.14309/crj.2016.15
State	Published - Jan 1 2016
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.14309/crj.2016.15

Cite this

@article{67374ded562e47ae81ab094511935efc,

title = "Ustekinumab for successful treatment of refractory esophageal crohn's disease",

abstract = "Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.",

author = "Barkin, {Jodie A.} and Deshpande, {Amar R.}",

year = "2016",

month = jan,

day = "1",

doi = "10.14309/crj.2016.15",

language = "English (US)",

volume = "3",

pages = "107--108",

journal = "ACG Case Reports Journal",

issn = "2326-3253",

publisher = "American College of Gastroenterology",

number = "2",

}

TY - JOUR

T1 - Ustekinumab for successful treatment of refractory esophageal crohn's disease

AU - Barkin, Jodie A.

AU - Deshpande, Amar R.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.

AB - Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.

UR - http://www.scopus.com/inward/record.url?scp=84992173766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992173766&partnerID=8YFLogxK

U2 - 10.14309/crj.2016.15

DO - 10.14309/crj.2016.15

M3 - Article

VL - 3

SP - 107

EP - 108

JO - ACG Case Reports Journal

JF - ACG Case Reports Journal

SN - 2326-3253

IS - 2

ER -

Ustekinumab for successful treatment of refractory esophageal crohn's disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this